Seven-year time course of lung function, symptoms, health-related quality of life, and exercise tolerance in COPD patients undergoing pulmonary rehabilitation programs

Respiratory Medicine

Volumn 101, Issue 9, 2007, Pages 1961-1970

  Foglio, Katia ^a   Bianchi, Luca ^a   Bruletti, Gisella ^a   Porta, Roberto ^a   Vitacca, Michele ^a   Balbi, Bruno ^b   Ambrosino, Nicolino ^c  

^a Scientific Institute of Gussago   (Italy)

^b IRCCS   (Italy)

^c UNIVERSITY HOSPITAL OF PISA   (Italy)

Author keywords

Dyspnoea; Exercise tolerance; Health related quality of life

Indexed keywords

ADULT; AGED; ARTICLE; BICYCLE ERGOMETRY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL EFFECTIVENESS; DISEASE COURSE; DYSPNEA; EXERCISE; EXERCISE TOLERANCE; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; HEALTH PROGRAM; HUMAN; LONG TERM CARE; LUNG FUNCTION; MALE; OBSERVATIONAL STUDY; OUTCOMES RESEARCH; PRIORITY JOURNAL; PULMONARY REHABILITATION; QUALITY OF LIFE; SCORING SYSTEM; SYMPTOMATOLOGY; WALKING;

AGED; CARBON DIOXIDE; DISEASE PROGRESSION; DYSPNEA; EXERCISE TOLERANCE; FEMALE; FORCED EXPIRATORY VOLUME; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; OXYGEN; PARTIAL PRESSURE; PROGRAM EVALUATION; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; RESPIRATORY MUSCLES; VITAL CAPACITY;

EID: 34547421339     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2007.04.007     Document Type: Article

References (44)

1. Global initiative for chronic obstructive lung disease. Workshop report, global strategy for diagnosis, management, and prevention of COPD. Update September 2005. Bethesda, MD: National Institutes of Health, National Heart, Lung and Blood Institute; 2005. Available from: 〈www.goldcopd.com〉.
2. Downs S.H., Brandli O., Zellweger J.P., et al. Accelerated decline in lung function in smoking women with airway obstruction: SAPALDIA 2 cohort study. Respir Res 26 (2005) 45
3. Pitta F., Troosters T., Spruit M.A., Probst V.S., Decramer M., and Gosselink R. Characteristics of physical activities in daily life in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 171 (2005) 972-977
4. Nici L, Donner C, Wouters E, et al. on behalf of the ATS/ERS Pulmonary Rehabilitation Writing Committee. American Thoracic Society/European Respiratory Society Statement on Pulmonary Rehabilitation. Am J Respir Crit Care Med 2006;173:1390-413.
5. Griffiths T.L., and Bourbeau J. The economics of pulmonary rehabilitation and self-management education for patients with chronic obstructive pulmonary disease. In: Donner C.F., Ambrosino N., and Goldstein R.S. (Eds). Pulmonary rehabilitation (2005), Arnold Pub, London 164-172
6. Foglio K., Bianchi L., Bruletti G., Battista L., Pagani M., and Ambrosino N. Long-term effectiveness of pulmonary rehabilitation in patients with chronic airway obstruction (CAO). Eur Respir J 13 (1999) 125-132
7. Foglio K., Bianchi L., and Ambrosino N. Is it really useful to repeat outpatient pulmonary rehabilitation programs in patients with chronic airway obstruction? A 2-year controlled study. Chest 119 (2001) 1696-1704
8. Maltais F., LeBlanc P., Jobin J., et al. Intensity of training and physiologic adaptation in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 155 (1997) 555-561
9. Clark C.J., Cochrane L., and Mackay E. Low intensity peripheral muscle conditioning improves exercise tolerance and breathlessness in COPD. Eur Respir J 9 (1996) 2590-2596
10. Celli B.R., MacNee W., Agusti A., et al. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 23 (2004) 932-946
11. Quanjer P.H. Working party on "Standardization of lung function test". Bull Eur Physiopathol Respir 19 Suppl. 5 (1983) 7-10
12. Black L., and Hyatt R. Maximal airway pressures: normal values and relationship to age and sex. Am Rev Respir Dis 99 (1969) 696-702
13. Bruschi C., Cerveri I., Zoia M.C., et al. Reference values of maximal respiratory mouth pressures: a population-based study. Am Rev Respir Dis 146 (1992) 790-793
14. American Thoracic Society. Single-breath carbon monoxide diffusing capacity (transfer factor): recommendations for a standard technique, 1995 upadate. Am J Respir Crit Care Med 152 (1995) 2185-2198
15. Crapo R.O., and Morris A.H. Standardized single breath normal values for carbon monoxide diffusing capacity. Am Rev Respir Dis 123 (1981) 185-189
16. Borg G.A.V. Psychophysical basis of perceived exertion. Med Sci Sports Exerc 14 (1992) 377-381
17. American Thoracic Society- ATS Statement. Guidelines for the six-minute walk test. Am J Respir Crit Care Med 166 (2002) 111-117
18. Fletcher C.M. Standardised questionnaire on respiratory symptoms: a statement prepared and approved by the MRC committee on the aetiology of Chronic Bronchitis (MRC breathlessness score). Br Med J 2 (1960) 1665
19. Mahler D.A., Guyatt G.H., and Jones P.W. Clinical measurements of dyspnea. In: Mahler D.A. (Ed). Dyspnea (1998), Marcel Dekker, New York 149-198
20. Jones P.W., Quirk F.H., Baveystock C.M., et al. A self-complete measure of health status for chronic airflow limitation. Am Rev Respir Dis 145 (1992) 1321-1327
21. Carone M., Bertolotti G., Zotti A.M., et al. Validation of the St. George's respiratory questionnaire-Italian version. Eur Respir J 10 Suppl. 25 (1997) 457S
22. Celli B.R., Cote C.G., Marin J.M., et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 350 (2004) 1005-1012
23. Redelmeier D.A., Bayoumi A.M., Goldstein R.S., et al. Interpreting small differences in functional status: the six minute walk test in chronic lung disease patients. Am J Respir Crit Care Med 155 (1997) 1278-1282
24. Carone M., and Jones P.W. Impact of health status ('quality of life') issues in chronic lung disease. In: Donner C.F., Ambrosino N., and Goldstein R.S. (Eds). Pulmonary rehabilitation (2005), Arnold Pub, London 164-172
25. Burge P.S., Calverley P.M.A., Jones P.W., et al. Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial. Br Med J 320 (2000) 1297-1303
26. Calverley PMA, Anderson JA, Celli B, et al., for the TORCH investigators. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med 2007;356:775-89.
27. Doll R., Peto R., Boreham J., et al. Mortality in relation to smoking: 50 years' observations on male British doctors. Br Med J 328 (2004) 1519-1527
28. Garcia-Aymerich J., Lange P., Benet M., Schnohr P., and Anto J.M. Regular physical activity reduces hospital admission and mortality in chronic obstructive pulmonary disease: a population based cohort study. Thorax 61 (2006) 772-778
29. Cote C.G., and Celli B.R. Pulmonary rehabilitation and the BODE index in COPD. Eur Respir J 26 (2005) 630-636
30. Garcia-Aymerich J., Lange P., Benet M., Schnohr P., and Anto J.M. Regular physical activity modifies smoking-related lung function decline and reduces risk of Chronic Obstructive Pulmonary Disease. A population-based cohort study. Am J Respir Crit Care Med 175 (2007) 458-463
31. Vitacca M., Bianchi L., Ziliani M., Sarvà M., and Ambrosino N. Effects of acute on chronic respiratory failure on hypercapnia and three-month survival. Chest 128 (2005) 1209-1215
32. Vitacca M., Bianchi L., Barbano L., and Ambrosino N. Lung and respiratory muscle function at discharge from a respiratory intensive care unit. Monaldi Arch Chest Dis 63 (2005) 142-148
33. Donaldson G.C., Seemungal T.A.R., Bhowmik A., et al. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax 57 (2002) 847-852
34. Seemungal T.A.R., Donaldson G.C., Bhowmik A., et al. Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 161 (2000) 1608-1613
35. Weiner P., and McConnell A. Respiratory muscle training in chronic obstructive pulmonary disease: inspiratory, expiratory or both?. Curr Opin Pulm Med 11 (2005) 140-144
36. Turner S.E., Eastwood P.R., Cecins N.M., et al. Physiologic responses to incremental and self-paced exercise in COPD: a comparison of three tests. Chest 126 (2004) 766-773
37. Oga T., Nishimura K., Tsukino M., et al. Exercise capacity deterioration in patients with COPD. Longitudinal evaluation over 5 years. Chest 128 (2005) 62-69
38. Oga T., Nishimura K., Tsukino M., et al. Analysis of the factors related to mortality in chronic obstructive pulmonary disease: role of exercise capacity and health status. Am J Respir Crit Care Med 167 (2003) 544-549
39. Pinto-Plata V.M., Cote C., Cabral H., et al. The 6-min walk distance: change over time and value as a predictor of survival in severe COPD. Eur Respir J 23 (2004) 28-33
40. Nishimura K., Izumi T., Tsukino M., et al. Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD. Chest 121 (2002) 1434-1440
41. Spencer S., Calverley P.M., Sherwood Burge P., et al. Inhaled steroids in obstructive lung disease. Health status deterioration in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 163 (2001) 122-128
42. Reardon J., Patel K., and ZuWallack R.L. Improvement in quality of life is unrelated to improvement in exercise endurance after outpatient pulmonary rehabilitation. J Cardiopulm. Rehabil 13 (1993) 51-54
43. Osman L.M., Godden D.J., Friend J.A.R., et al. Quality of life and hospital re-admission in patients with chronic obstructive pulmonary disease. Thorax 52 (1997) 67-71
44. Seemungal T.A.R., Donaldson G.C., Paul E.A., et al. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 157 (1998) 1418-1422